Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study

Br J Haematol. 2021 Mar;192(5):e121-e124. doi: 10.1111/bjh.17260. Epub 2021 Feb 1.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Allografts
  • COVID-19 / complications*
  • COVID-19 / diagnostic imaging
  • COVID-19 / mortality
  • Child
  • Child, Preschool
  • Cohort Studies
  • France / epidemiology
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Kaplan-Meier Estimate
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • SARS-CoV-2*
  • Thrombocytopenia / etiology
  • Transplantation Conditioning / adverse effects
  • Young Adult

Substances

  • Immunosuppressive Agents